HIV & AIDS

HIV/AIDS research yields dividends across medical fields

Since the first cases of AIDS were reported in the United States 37 years ago, the National Institutes of Health has invested more than $69 billion in the understanding, treatment and prevention of HIV/AIDS. Beyond the development ...

HIV & AIDS

Healthy competition intensifies 30-year quest for HIV vaccine

In 1984, after HIV was identified as the cause of AIDS, the US secretary of health, Margaret Heckler, declared a vaccine would be found within two years. Reports of a mysterious virus predominantly affecting gay men had been ...

HIV & AIDS

Scientists discover new way that HIV evades the immune system

Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a ...

Oncology & Cancer

Immune response to HIV virus linked to cancer mutations

"Our findings could change the way we treat cancer," said microbiology professor Linda Chelico. Her research, funded by the federal agency NSERC, was recently published in Nucleic Acids Research and a related project was ...

Diseases, Conditions, Syndromes

Synthetic molecule 'kicks and kills' some persistent HIV in mice

Scientists have designed a synthetic molecule that can reactivate dormant human immunodeficiency virus (HIV) in mice and lead to the death of some of the infected cells, according to a study published in PLOS Pathogens.

Oncology & Cancer

Cancer and HIV—closing the screening gap

While collaborating with clinical colleagues in rural southwest Georgia, Emory cancer researcher Theresa Gillespie learned a surprising fact. The region has one of the state's largest HIV/AIDS populations outside of metropolitan ...

page 7 from 13